ABAbbVie ABBV · NYSE
$286.35 -0.01% (-$0.04)
- Market cap
- $506.2B
- Enterprise value
- $570.4B
- P/E
- 80.2x
- Forward P/E
- 20.5x
- PEG
- -
- P/S
- 7.9x
- P/FCF
- 25.7x
- EV/EBITDA
- 26.9x
- ROIC
- 13.5%
- Gross margin
- 71.5%
- Net margin
- 9.8%
- Dividend yield
- 2.42%
- Payout ratio
- 193.7%
- Net debt/EBITDA
- 3.0x
- Beta
- 0.28
- Free float
- 99.8%
About the company
AbbVie (ABBV) is a global pharmaceutical company specializing in the development and manufacturing of innovative medicines. Their portfolio includes drugs in the areas of immunology, oncology, neuroscience, and other therapeutic areas. With strong research and development capabilities, AbbVie offers a promising investment opportunity for long-term focused investors in the healthcare sector. Add ABBV stock to your watchlist on Bulios and stay informed about the latest news and innovations in the pharmaceutical industry.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert A. Michael
Employees
57,000
Headquarters
North Chicago
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 10% this fiscal year.
- What to watch: Earnings per share fell by 29% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 31 USD is left as free cash.
- What speaks for it: It earns 13 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It has raised its dividend 12 years in a row.
- What to watch: It pays out more in dividends than it earns: 194% of profit.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number